Fostamatinib combined with TPO-RAs or steroids as a bridge to monotherapy or as time-limited continuous treatment in relapsed chronic ITP: A single-centre case series

Br J Haematol. 2024 May;204(5):2129-2132. doi: 10.1111/bjh.19450. Epub 2024 Apr 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aminopyridines* / administration & dosage
  • Aminopyridines* / therapeutic use
  • Chronic Disease
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Morpholines* / administration & dosage
  • Morpholines* / therapeutic use
  • Oxazines / administration & dosage
  • Oxazines / therapeutic use
  • Purpura, Thrombocytopenic, Idiopathic* / drug therapy
  • Pyridines* / administration & dosage
  • Pyridines* / therapeutic use
  • Pyrimidines / administration & dosage
  • Pyrimidines / therapeutic use
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / therapeutic use
  • Recurrence
  • Steroids / administration & dosage
  • Steroids / therapeutic use

Substances

  • fostamatinib
  • Pyridines
  • Aminopyridines
  • Morpholines
  • Oxazines
  • Pyrimidines
  • Steroids
  • Recombinant Fusion Proteins